LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.08 | 27.76 | 3439 | 6849 | 0.5021 | 0.8339 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.08 | 27.76 | 173 | 6849 | 0.0253 | 0.2589 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.08 | 27.76 | 4230 | 6849 | 0.6175 | 0.8823 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.78 | 27.76 | 77 | 6893 | 0.0112 | 0.1368 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.78 | 27.76 | 3552 | 6893 | 0.5153 | 0.8401 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.78 | 27.76 | 157 | 6893 | 0.0228 | 0.2433 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.78 | 27.76 | 4392 | 6893 | 0.6372 | 0.8898 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.48 | 27.76 | 84 | 6957 | 0.0121 | 0.1491 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.48 | 27.76 | 3666 | 6957 | 0.5269 | 0.8455 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.48 | 27.76 | 144 | 6957 | 0.0207 | 0.2295 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.48 | 27.76 | 4551 | 6957 | 0.6541 | 0.8963 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.19 | 27.76 | 93 | 7015 | 0.0133 | 0.1636 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.19 | 27.76 | 3779 | 7015 | 0.5387 | 0.8508 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.19 | 27.76 | 136 | 7015 | 0.0194 | 0.2203 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.19 | 27.76 | 4645 | 7015 | 0.6621 | 0.8993 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.89 | 27.76 | 92 | 7025 | 0.0131 | 0.1619 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.89 | 27.76 | 3872 | 7025 | 0.5512 | 0.8562 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.89 | 27.76 | 150 | 7025 | 0.0214 | 0.2353 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.89 | 27.76 | 4816 | 7025 | 0.6855 | 0.9076 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.60 | 27.76 | 80 | 7045 | 0.0114 | 0.1417 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.60 | 27.76 | 3974 | 7045 | 0.5640 | 0.8616 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.60 | 27.76 | 148 | 7045 | 0.0210 | 0.2331 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.60 | 27.76 | 4973 | 7045 | 0.7058 | 0.9146 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.31 | 27.76 | 91 | 6976 | 0.0130 | 0.1606 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.31 | 27.76 | 4061 | 6976 | 0.5821 | 0.8688 | MN20160318_Q01 | E22 |